These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1330047

  • 1. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG, Verheyden PM, Tourwe D, Van Binst G, Davis P, Burks TF.
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD, Nikiforovich GV, Golbraikh AA.
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [Abstract] [Full Text] [Related]

  • 5. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
    Weltrowska G, Nguyen TM, Chung NN, Wilkes BC, Schiller PW.
    Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5082-5. PubMed ID: 23932788
    [Abstract] [Full Text] [Related]

  • 6. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM, Ferguson RD, Knapp RJ, Lui GK, Yamamura HI, Hruby VJ.
    Int J Pept Protein Res; 1992 May 15; 39(5):401-14. PubMed ID: 1358847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C, Brandt W, Schmidt R, Neubert K, Schiller PW.
    Arch Pharm (Weinheim); 1996 Mar 09; 329(3):133-42. PubMed ID: 9005812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
    Wilkes BC, Schiller PW.
    Biopolymers; 1995 Mar 09; 37(6):391-400. PubMed ID: 8589244
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
    Schiller PW, Nguyen TM, Maziak LA, Wilkes BC, Lemieux C.
    J Med Chem; 1987 Nov 09; 30(11):2094-9. PubMed ID: 2822930
    [Abstract] [Full Text] [Related]

  • 15. Isolation and identification of peptide conformers by reversed-phase high-performance liquid chromatography and NMR at low temperature.
    Kálmán A, Thunecke F, Schmidt R, Schiller PW, Horváth C.
    J Chromatogr A; 1996 Apr 05; 729(1-2):155-71. PubMed ID: 9004937
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs.
    Gach K, do-Rego JC, Fichna J, Storr M, Delbro D, Toth G, Janecka A.
    Peptides; 2010 Aug 05; 31(8):1617-24. PubMed ID: 20434497
    [Abstract] [Full Text] [Related]

  • 17. Opioid activities of morphiceptin-like peptides latent in various natural proteins.
    Shimohigashi Y, Sakaguchi K, Sakamoto H, Waki M, Costa T.
    Pept Res; 1990 Aug 05; 3(5):216-23. PubMed ID: 1966866
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.
    Giordano C, Sansone A, Masi A, Lucente G, Punzi P, Mollica A, Pinnen F, Feliciani F, Cacciatore I, Davis P, Lai J, Ma SW, Porreca F, Hruby V.
    Eur J Med Chem; 2010 Oct 05; 45(10):4594-600. PubMed ID: 20692738
    [Abstract] [Full Text] [Related]

  • 19. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE, Portoghese PS.
    J Pharmacol Exp Ther; 1985 Nov 05; 235(2):389-92. PubMed ID: 2997432
    [Abstract] [Full Text] [Related]

  • 20. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T, Ro S, Goodman M.
    Biochem Biophys Res Commun; 1991 Dec 16; 181(2):664-70. PubMed ID: 1661586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.